Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Inject TRESIBA subcutaneously into the thigh, upper arm, or abdomen
The 1,400-patient STEP UP trial found an average weight loss of 21% with Wegovy 7.2 mg, with more than a quarter (27%) of people treated with that dose falling into the early responder category, and discontinuation rates due to side effects were at the same level as the 2.4 mg dose
Tirzepatide: The Dual-Acting Agonist Tirzepatide, found in Zepbound (for weight management) and Mounjaro (for type 2 diabetes), takes a dual-action approach
Instead of promoting extremes, patients receive guidance that supports balanced eating habits while fitting into everyday life
US$ 23.98
US$ 25.80
US$ 26.32
US$ 26.65
US$ 28.87
US$ 29.97
